HONG KONG--(Marketwire -06/14/12)- Today, www.EquityLeader.com introduced research coverage of Novartis AG (ADR) (NVS) and Bristol Myers Squibb Co. (BMY). Full research reports are available to readers at: www.EquityLeader.com/index.php?sm1=NVS&sm2=BMY.
With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Equity Leader has decided to cover Novartis AG (ADR) for its current position within the healthcare industry. Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. A copy of this report detailing Novartis AG (ADR) (NVS) is available at: www.EquityLeader.com/index.php?sm1=NVS.
Equity Leader is also taking note of Bristol Myers Squibb Co. for its changing role within the healthcare industry. Bristol-Myers Squibb Company (BMS) is a global biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Its products are sold worldwide to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. To download free research on Bristol Myers Squibb Co. (BMY) investors may visit: www.EquityLeader.com/index.php?sm2=BMY.
About Equity Leader
Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.
- Novartis AG